US Computer Vision in Healthcare Market to Reach $11.53 Billion by 2029
The US computer vision in healthcare market is expected to reach $11.53 billion by 2029, growing from $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 24.0%, announced in a press release. This growth is fueled by the increasing volume of medical imaging data, which necessitates efficient analysis methods. Computer vision technologies enhance diagnostic accuracy by automating processes, providing healthcare providers with precise tools for diagnosis and treatment planning.
In January 2025, the FDA released new draft guidance to expedite regulatory approvals for AI-enabled medical devices. This guidance aims to foster confidence in AI-driven healthcare solutions by addressing transparency, bias risk tactics, and whole product life cycle management. Despite these advancements, ensuring the accuracy and reliability of computer vision algorithms remains a challenge, as errors in complex medical imaging tasks can have serious consequences.
PC-based computer vision systems currently hold the largest market share due to their powerful, affordable, and dependable solutions for diagnostic centers and hospitals. These systems integrate seamlessly into existing medical workflows and offer greater control over sensitive patient data, ensuring HIPAA compliance. Additionally, their ability to function offline guarantees continuous operation, eliminating interruptions caused by connectivity issues.
The patient activity monitoring and fall prevention segment is also experiencing rapid growth, driven by an aging population and a stronger focus on elderly care. AI-based solutions, such as those rolled out by Caregility Corporation in 2024, use edge-based computer vision to monitor patient motion and notify caregivers in real-time, enhancing safety and expanding remote care options.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 LateralCare brings revenue alai to Microsoft Marketplace Sep 30 NYU Langone Tests AI Tool to Fill Radiology Training Gaps Sep 30 Healthcare Triangle Plans North American Humanoid Nursing Robot Venture Sep 30 Xtalks Plans Webinar on AI Governance in Clinical Development Sep 30 Suvoda Updates Clinical Trial Platform With AI and Unified AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
MarketsandMarkets Forecasts Edge AI Software Market at $120.31 Billion by 2032
MarketsandMarkets Forecasts Shadow AI Governance Market at $8.64 Billion by 2032
Bain Says AI Needs $6 Trillion in Annual Revenue by 2031
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
Daily AI Brief: the AI news that matters, in your inbox.